CB1R in Synthetic Psychoactive Cannabinoids
Running, not enrolling · Not applicable
Conditions studied: Drug Dependence
In brief
The purpose of this research study is to determine whether the CB1R availability is lower in synthetic psychoactive cannabinoid subjects using the most widely available synthetic psychoactive cannabinoids at the time the study is initiated.
Key facts
- Study ID
- NCT03539575
- Run by
- Yale University
- People needed
- 15
- Starts
- 2018-05-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-04-29
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Connecticut Mental Health Center — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.